Loading organizations...
UTC Investment is a prominent venture capital and private equity firm based in Seoul, South Korea. The firm specializes in providing strategic investments to companies primarily within the biotech, healthcare, and technology sectors. It deploys capital across various stages of a company's growth, supporting the development and scaling of innovative enterprises with its comprehensive investment approach.
Established in 1988, UTC Investment was founded with an insight into the need for an investment partner capable of fostering mutual growth between its limited partners and portfolio companies. Over more than three decades, the firm has built a substantial track record, participating in over 200 investments, which underscores its deep experience in navigating diverse market conditions and technology cycles within the Asian market.
The firm's focus is on partnering with innovative start-ups and growth-stage companies seeking capital and strategic guidance to expand their market presence and develop groundbreaking solutions. UTC Investment’s vision is to cultivate a dynamic ecosystem where technological and medical advancements can flourish, ultimately driving long-term value creation for its portfolio and contributing to the broader economic landscape.
UTC Investment has 7 tracked investments across 7 companies. The latest tracked deal is $8.9M Series A in Novorex in November 2023.